Immunogenicity of β-cells for autologous transplantation in type 1 diabetes.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Pharmacological Research

• Publication date

  2015-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.phrs.2015.03.003PMID 25801943
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-Term Efficacy of Insulin Pump Therapy on Glycemic Control in Adults with Type 1 Diabetes Mellitus

  2015cited by this paper
• The rise, fall, and resurgence of immunotherapy in type 1 diabetes.

  2015cited by this paper
• Human umbilical cord blood cells and diabetes mellitus: recent advances.

  2015cited by this paper
• Tolerance induction and reversal of diabetes in mice transplanted with human embryonic stem cell-derived pancreatic endoderm.

  2015cited by this paper
• Know Thyself: NK-Cell Inhibitory Receptors Prompt Self-Tolerance, Education, and Viral Control

  2014cited by this paper
• Outpatient glycemic control with a bionic pancreas in type 1 diabetes.

  2014cited by this paper
• Preserved β-Cell Function in Type 1 Diabetes by Mesenchymal Stromal Cells

  2014cited by this paper
• Elevated Mouse Hepatic Betatrophin Expression Does Not Increase Human β-Cell Replication in the Transplant Setting

  2014cited by this paper
• Rethinking clinical delivery of adult stem cell therapies

  2014cited by this paper
• Glycemic control and excess mortality in type 1 diabetes.

  2014cited by this paper
• Immune modulation in humans: implications for type 1 diabetes mellitus

  2014cited by this paper
• Long‐Term Results in Recipients of Combined HLA‐Mismatched Kidney and Bone Marrow Transplantation Without Maintenance Immunosuppression

  2014cited by this paper
• Encapsulated islets for diabetes therapy: history, current progress, and critical issues requiring solution.

  2014cited by this paper
• Japan stem-cell trial stirs envy

  2014cited by this paper
• Editorial: Bringing regenerative medicine therapies to the 21st century.

  2014cited by this paper
• Induction of tolerance through mixed chimerism.

  2014cited by this paper
• Betatrophin Versus Bitter-Trophin and the Elephant in the Room: Time for a New Normal in β-Cell Regeneration Research

  2014cited by this paper
• An effective approach to prevent immune rejection of human ESC-derived allografts.

  2014cited by this paper
• Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells

  2014cited by this paper
• Primate adult brain cell autotransplantation produces behavioral and biological recovery in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced parkinsonian St. Kitts monkeys

  2014cited by this paper
• Heterelogous expression of mutated HLA-G decreases immunogenicity of human embryonic stem cells and their epidermal derivatives.

  2014cited by this paper
• Generation of functional human pancreatic β cells in vitro.

  2014cited by this paper
• Composition and function of macroencapsulated human embryonic stem cell-derived implants: comparison with clinical human islet cell grafts.

  2014cited by this paper
• Transplanted Terminally Differentiated Induced Pluripotent Stem Cells Are Accepted By Immune Mechanisms Similar To Self-Tolerance

  2014cited by this paper
• MHC-Matched Induced Pluripotent Stem Cells Can Attenuate Cellular and Humoral Immune Responses but Are Still Susceptible to Innate Immunity in Pigs

  2014cited by this paper
• Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells

  2014cited by this paper
• Characterization of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cell Sheets Aiming for Clinical Application

  2014cited by this paper
• Islet and stem cell encapsulation for clinical transplantation.

  2014cited by this paper
• Betatrophin: a hormone that controls pancreatic β cell proliferation.

  2013cited by this paper
• The evolving field of induced pluripotency: Recent progress and future challenges

  2013cited by this paper
• Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells.

  2013cited by this paper
• Maturation and function of human embryonic stem cell-derived pancreatic progenitors in macroencapsulation devices following transplant into mice

  2013cited by this paper
• Exploiting Apoptosis for Therapeutic Tolerance Induction

  2013cited by this paper
• Immune Monitoring of Islet and Pancreas Transplant Recipients

  2013cited by this paper
• Deterministic direct reprogramming of somatic cells to pluripotency

  2013cited by this paper
• Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells

  2013cited by this paper
• Stem cells cruise to clinic

  2013cited by this paper
• Alloantibody and Autoantibody Monitoring Predicts Islet Transplantation Outcome in Human Type 1 Diabetes

  2013cited by this paper
• Intracerebral Transplantation of Differentiated Human Embryonic Stem Cells to Hemiparkinsonian Monkeys

  2013cited by this paper
• Progress in immune‐based therapies for type 1 diabetes

  2013cited by this paper
• Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain.

  2013cited by this paper
• Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.

  2013cited by this paper
• Direct Comparison of Autologous and Allogeneic Transplantation of iPSC-Derived Neural Cells in the Brain of a Nonhuman Primate

  2013cited by this paper
• Islet encapsulation: advances and obstacles

  2013cited by this paper
• Immunosequencing: applications of immune repertoire deep sequencing.

  2013cited by this paper
• Risk of Cardiovascular Disease and Total Mortality in Adults with Type 1 Diabetes: Scottish Registry Linkage Study

  2012cited by this paper
• Improvement in Outcomes of Clinical Islet Transplantation: 1999–2010

  2012cited by this paper
• Trends in Death Rates Among U.S. Adults With and Without Diabetes Between 1997 and 2006

  2012cited by this paper
• Clinical Islet Xenotransplantation

  2012cited by this paper
• BIOMARKERS OF OPERATIONAL TOLERANCE IN SOLID ORGAN TRANSPLANTATION.

  2012cited by this paper
• Systematic review of total pancreatectomy and islet autotransplantation for chronic pancreatitis

  2012cited by this paper
• Potent Induction Immunotherapy Promotes Long‐Term Insulin Independence After Islet Transplantation in Type 1 Diabetes

  2012cited by this paper
• Clinical xenotransplantation: the next medical revolution?

  2012cited by this paper
• Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus

  2012cited by this paper
• Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types.

  2012cited by this paper
• Type 1 diabetes: etiology, immunology, and therapeutic strategies.

  2011cited by this paper
• Rapamycin Impairs Proliferation of Transplanted Islet &bgr; Cells

  2011cited by this paper
• Immunogenicity of induced pluripotent stem cells

  2011cited by this paper
• CD40‐Specific Costimulation Blockade Enhances Neonatal Porcine Islet Survival in Nonhuman Primates

  2011cited by this paper
• Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells.

  2011cited by this paper
• A more efficient method to generate integration-free human iPS cells

  2011cited by this paper
• Systematic review and meta‐analysis: islet autotransplantation after pancreatectomy for minimizing diabetes

  2011cited by this paper
• Immunological applications of stem cells in type 1 diabetes.

  2011cited by this paper
• Karyotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells

  2011cited by this paper
• Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells

  2011cited by this paper
• Immunogenicity of induced pluripotent stem cells.

  2011cited by this paper
• Recurrence of Autoimmunity Following Pancreas Transplantation

  2011cited by this paper
• Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers.

  2011cited by this paper
• Identification of a gene expression profile associated with operational tolerance among a selected group of stable kidney transplant patients

  2011cited by this paper
• Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells

  2011cited by this paper
• Immunogenicity of embryonic stem cell-derived progenitors after transplantation

  2011cited by this paper
• Islet Transplantation in Type 1 Diabetic Patients Using Calcineurin Inhibitor-Free Immunosuppressive Protocols Based on T-Cell Adhesion or Costimulation Blockade

  2010cited by this paper
• Recurrence of Type 1 Diabetes After Simultaneous Pancreas-Kidney Transplantation, Despite Immunosuppression, Is Associated With Autoantibodies and Pathogenic Autoreactive CD4 T-Cells

  2010cited by this paper
• Ascorbate Promotes Epigenetic Activation of CD30 in Human Embryonic Stem Cells

  2010cited by this paper
• Islet Transplantation in Type 1 Diabetics Using an Immunosuppressive Protocol Based on the Anti‐LFA‐1 Antibody Efalizumab

  2010cited by this paper
• Simultaneous Detection of Circulating Autoreactive CD8+ T-Cells Specific for Different Islet Cell–Associated Epitopes Using Combinatorial MHC Multimers

  2010cited by this paper
• Short-Term Administrations of a Combination of Anti–LFA-1 and Anti-CD154 Monoclonal Antibodies Induce Tolerance to Neonatal Porcine Islet Xenografts in Mice

  2010cited by this paper
• Conversion of Adult Pancreatic α-cells to β-cells After Extreme β-cell Loss

  2010cited by this paper
• Nuclear reprogramming to a pluripotent state by three approaches

  2010cited by this paper
• A Novel Clinically Relevant Strategy to Abrogate Autoimmunity and Regulate Alloimmunity in NOD Mice

  2010cited by this paper
• Safety and Viability of Microencapsulated Human Islets Transplanted Into Diabetic Humans

  2009cited by this paper
• Genetics of type 1A diabetes.

  2009cited by this paper
• Accumulation of autoreactive effector T cells and allo-specific regulatory T cells in the pancreas allograft of a type 1 diabetic recipient

  2009cited by this paper
• Teratoma Formation by Human Embryonic Stem Cells Is Site Dependent and Enhanced by the Presence of Matrigel

  2009cited by this paper
• Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells under Xeno‐free Conditions

  2009cited by this paper
• Transplantation Research: Will We Ever Reach the Holy Grail?

  2009cited by this paper
• Sustained Benefit of Continuous Glucose Monitoring on A1C, Glucose Profiles, and Hypoglycemia in Adults With Type 1 Diabetes

  2009cited by this paper
• C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.

  2009cited by this paper
• Restoration of Hypoglycemia Awareness After Islet Transplantation

  2008cited by this paper
• Embryonic Stem Cells and Their Differentiated Derivatives Have a Fragile Immune Privilege but Still Represent Novel Targets of Immune Attack

  2008cited by this paper
• Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years

  2008cited by this paper
• Absence of transmission of potentially xenotic viruses in a prospective pig to primate islet xenotransplantation study

  2008cited by this paper
• A Multi-Year Analysis of Islet Transplantation Compared With Intensive Medical Therapy on Progression of Complications in Type 1 Diabetes

  2008cited by this paper
• In vivo reprogramming of adult pancreatic exocrine cells to β-cells

  2008cited by this paper
• HLA-mismatched renal transplantation without maintenance immunosuppression.

  2008cited by this paper
• Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation

  2008cited by this paper
• Chimerism and tolerance in a recipient of a deceased-donor liver transplant.

  2008cited by this paper
• Tolerance and chimerism after renal and hematopoietic-cell transplantation.

  2008cited by this paper
• Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways

  2006cited by this paper
• Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases.

  2006cited by this paper

• Stem Cell-Derived Beta-Cell Therapies: Encapsulation Advances and Immunological Hurdles in Diabetes Treatment

  2026cites this paper
• Significance of neuroendocrine systems and the gut-brain axis (GBA) in the regulation of obesity

  2026cites this paper
• Further perspectives and challenges

  2022cites this paper
• Human embryonic stem cells (hESC) as a source of insulin-producing cells

  2020cites this paper
• Progress toward islet transplantation tolerance

  2020cites this paper
• New Trends in Stem Cell Transplantation in Diabetes Mellitus Type I and Type II

  2017cites this paper
• Cell based therapeutics in type 1 diabetes mellitus.

  2017cites this paper
• &bgr; Cell Replacement Therapy: The Next 10 Years

  2017cites this paper
• miR-145 modulates lncRNA-ROR and Sox2 expression to maintain human amniotic epithelial stem cell pluripotency and β islet-like cell differentiation efficiency.

  2016cites this paper
• Pengaruh Transplantasi Allograf Pancreatic Stem Cell terhadap Kadar Insulin dan C-Peptide Tikus Putih Penderita Diabetes Melitus Tipe I

  2016cites this paper
• Islet Cell Transplantion: Update on Current Clinical Trials

  2016cites this paper
• Novel therapies for T1D on the horizon.

  2015cites this paper
• Pluripotent stem cell applications for regenerative medicine

  2015cites this paper